Skip to content
Screener

Maze Therapeutics MAZE Q1 2025 Annual earnings

Reported May 14, 2025 · Before market open

EPS-$1.15Miss by $0.39
EPS estimate-$0.76

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$333.3K
EPS estimate-$0.79

Financials

Q1 2025

Income statement

See full
Operating income-$35.4M-26.4%
Net income-$32.8M-0.9%
EPS (diluted)-$1.15+91.7%

Balance sheet

See full
Cash & equivalents$294.4M+880%
Total debt$25.8M—
Total equity$292.1M—
Total assets$332.8M—

Cash flow

See full
Operating cash flow-$29.5M-25.9%
CapEx$299.0K+7.2%
Free cash flow-$29.8M-25.7%

Segments

By geography

See full
US-—

FAQ

When did Maze Therapeutics report Q1 2025 earnings?
Maze Therapeutics (MAZE) reported Q1 2025 earnings on May 14, 2025 before market open.
What were Maze Therapeutics's Q1 2025 revenue and EPS?
Maze Therapeutics reported eps of $-1.15 for Q1 2025.
Did Maze Therapeutics beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.76 by $0.39.
Where can I find Maze Therapeutics's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-071357) and the 10-K periodic report (0000950170-25-047208) directly on SEC EDGAR. The filing index links above go to sec.gov.